RxDoctor Payments Data

Danielle Mrkvicka, NP

Gerontology · Minneapolis, MNNPI 1740804350

Payments from drug & device makers

What this record shows

Medtronic accounts for 94.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $2,231, more than ten times the $29 reported in 2023. Among gerontology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,010in general payments, 2019–2025

Across 40 payments — averaging $100.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Biosense Webster, Inc.$61
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$32
  • Pfizer$29
  • Novartis$23
  • Boston Scientific$18
  • plus $66 from 4 others

What the payments were for

  • Travel & lodging$2,33458%
  • Food & beverage$1,67642%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,010 in reported general payments places this provider in the 95th percentile of 106 gerontology providers in Minnesota.

See all gerontology providers in Minnesota

Medicare billing

Part B allowed, 2024
$15,086
Medicare patients
162
Services billed
202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$21,379
Dofetilide23$5,502
Metoprolol Succinate36$480
Amiodarone Hcl41$464
SotalolSotalol Hcl33$355
Pantoprazole Sodium52$273
Metoprolol Tartrate15$59
Furosemide58$39

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$29$21,37929 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 106 gerontology providers in Minnesota.

Other gerontology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →